Bo Liang

Chief Executive Officer at IVIEW Therapeutics.

Raised on IVIEW Therapeutics filings

$9.2M

of $15M offered across 2 Form D filings

Company

Biotech · Cranbury, NJ

Eyelid wipe drug for dry eye disease

Eyelid wipe drug for dry eye disease

IVIEW Therapeutics Form D filings
Filed	Security	Sold of offered	Filing
Jun 10, 2025	Equity	$9.2M/ $15M	Form D/A
Feb 24, 2025	Equity	$7.7M/ $15M	Form D/A

Also named on IVIEW Therapeutics filings